Company intelligence / Profile preview

Noetic Fund II

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Noetic Fund II is a venture capital fund that primarily invests in early-stage companies focused on psychedelic biotechnology, CNS-focused therapeutics, and related wellness technologies. Its investment scope includes solutions for mental health, substance use disorders, inflammation, and neurological/psychiatric disorders. It is the second fund managed by Noetic, following Noetic Psychedelic Fund LP.

Therapeutic areas: PsychiatryImmunologyNeurology
Industry: Investors

Beyond the preview

Go deeper on Noetic Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noetic Fund II.

Explore the full profile